In our study, SPINK1 is overexpressed in metastatic prostate cancer patients and associated with poor survival, and knocking down SPINK1 in the Enz-resistant cells significantly decreased their migration and invasiveness, and opposite effects were seen following SPINK1 overexpression in the Enz-sensitive cells. This evidence concerns the gene SPINK1 and metastatic prostate carcinoma.